Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer
Condition: Triple Negative Breast Cancer Interventions: Drug: Ipatasertib; Drug: Capecitabine; Drug: Eribulin; Drug: Carboplatin; Drug: Gemcitabine Sponsors: MedSIR; Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials